ArticleCureus2026
Simultaneous ST-Elevation Myocardial Infarction and Ischemic Stroke: A Therapeutic Dilemma and a Case for Deferred Revascularization.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The simultaneous occurrence of acute ischemic stroke and ST-elevation myocardial infarction (STEMI), termed cardio-cerebral infarction (CCI), represents a rare and challenging emergency due to competing therapeutic priorities. No clear guidelines currently exist to guide management in such cases. A 63-year-old male with uncontrolled hypertension presented with 48 hours of progressive dyspnea and epigastric discomfort, followed by sudden-onset left hemiplegia and dysarthria. On admission, brain CT revealed a right middle cerebral artery infarction without hemorrhage. ECG showed inferior STEMI, and troponin levels were elevated. Given the high hemorrhagic risk, urgent coronary angiography was deferred. A conservative strategy was adopted with aspirin (75 mg/day) and intermediate-dose low-molecular-weight heparin (enoxaparin 40 mg BID), initiated within six hours of neuroimaging. The patient's neurological status gradually improved, with National Institutes of Health Stroke Scale scores decreasing from 17 at admission to 10 at discharge, and a modified Rankin Score of 3. One month later, he reported recurrent angina. Coronary angiography revealed spontaneous reperfusion of the right coronary artery, allowing successful percutaneous coronary intervention with three stents. This case illustrates a stroke-first approach based on neurologic severity and hemodynamic stability. Antithrombotic management balanced ischemic and hemorrhagic risks. Timely neurologic improvement allowed deferred but successful revascularization, emphasizing the importance of individualized care in CCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.